CMSRN 3 EXAM QUESTIONS WITH CORRECT
ANSWERS
Antidiuretic |hormone |(ADH) |is |synthesized |in |the:
A. |Hypothalamus
B. |Pituitary |gland
C. |Pineal |gland
D. |Thalamus |- |CORRECT |ANSWER✔✔-A. |Hypothalamus
Antidiuretic |hormone |is |an |example |of |a |neuroendocrine |hormone; |it |has |components |of |both
|the |endocrine |and |the |nervous |system. |It |is |synthesized |in |the |hypothalamus |and |travels |
along |axons |that |terminate |adjacent |to |capillaries |in |the |posterior |pituitary.
The |physician |has |ordered |chlorpropamide |(Diabinese) |to |treat |a |patient |with |central |diabetes
|insipidus. |The |nurse |is |aware:
A. |Contraindications |include |heart |disease |and |renal |insufficiency
B. |Usual |dosing |in |diabetes |insipidus |is |100 |mg |daily
C. |This |medication |is |an |oral |hypoglycemic
D. |This |medication |suppresses |the |release |of |vasopressin |- |CORRECT |ANSWER✔✔-C. |This |
medication |is |an |oral |hypoglycemic
Chlorpropamide |is |an |oral |hypoglycemic |(first |generation |sulfonylurea). |It |lowers |blood |glucose
|levels |by |enhancing |pancreatic |beta-cell |insulin |secretion |(primary |use). |It |also |potentiates |the
|action |(not |suppresses |the |release) |of |small |or |residual |amounts |of |circulating |vasopressin |
(ADH), |making |it |useful |in |treating |diabetes |insipidus |(hyposecretion |of |ADH). |Usual |dosing |in |
diabetes |insipidus |is |125-500 |mg |daily. |
Contraindications |include |liver |disease |(not |heart |disease) |and |renal |insufficiency.
, In |patients |with |diabetes |mellitus |who |have |normal |renal |function, |protein |intake |should |be:
A. |30%-35% |of |daily |caloric |intake
B. |20%-25% |of |daily |caloric |intake
C. |15%-20% |of |daily |caloric |intake
D. |5%-10% |of |daily |caloric |intake |- |CORRECT |ANSWER✔✔-C. |15%-20% |of |daily |caloric |intake
In |patients |with |diabetes |mellitus, |who |have |normal |renal |function, |there |is |little |evidence |to |
suggest |that |usual |protein |intake |(15-20% |of |daily |caloric |intake) |should |be |modified. |With |
evidence |of |neuropathy, |it |may |be |necessary |to |restrict |protein |to |the |adult.
You |are |caring |for |a |patient |with |Type |2 |diabetes |mellitus |who |has |been |prescribed |glipizide |
(Glucotrol), |an |oral |antidiabetic |agent, |for |trouble |controlling |blood |glucose |levels |through |diet
|and |exercise |alone. |Which |medication |instruction |should |you |provide |to |the |patient?
A. |"After |you |start |taking |glipizide, |you |won't |need |to |check |your |blood |glucose |levels |
anymore."
B. |"Take |glipizide |after |meals |to |prevent |heartburn."
C. |"Glipizide |may |cause |a |low |serum |sodium |level, |so |be |sure |to |have |your |sodium |level |
checked |monthly."
D. |"Be |sure |to |take |glipizide |30 |minutes |before |meals." |- |CORRECT |ANSWER✔✔-D. |"Be |sure |to
|take |glipizide |30 |minutes |before |meals."
The |patient |should |be |instructed |to |take |glipizide |twice |a |day, |30 |minutes |before |a |meal |
because |food |decreases |its |absorption.
All |of |the |following |statements |related |to |carbohydrate |intake |in |the |diabetic |patient |are |true |
except:
A. |Low-carbohydrate |diets |which |restrict |total |carbohydrates |to |less |than |130/g |day |are |
recommended |in |the |management |of |diabetes |mellitus
ANSWERS
Antidiuretic |hormone |(ADH) |is |synthesized |in |the:
A. |Hypothalamus
B. |Pituitary |gland
C. |Pineal |gland
D. |Thalamus |- |CORRECT |ANSWER✔✔-A. |Hypothalamus
Antidiuretic |hormone |is |an |example |of |a |neuroendocrine |hormone; |it |has |components |of |both
|the |endocrine |and |the |nervous |system. |It |is |synthesized |in |the |hypothalamus |and |travels |
along |axons |that |terminate |adjacent |to |capillaries |in |the |posterior |pituitary.
The |physician |has |ordered |chlorpropamide |(Diabinese) |to |treat |a |patient |with |central |diabetes
|insipidus. |The |nurse |is |aware:
A. |Contraindications |include |heart |disease |and |renal |insufficiency
B. |Usual |dosing |in |diabetes |insipidus |is |100 |mg |daily
C. |This |medication |is |an |oral |hypoglycemic
D. |This |medication |suppresses |the |release |of |vasopressin |- |CORRECT |ANSWER✔✔-C. |This |
medication |is |an |oral |hypoglycemic
Chlorpropamide |is |an |oral |hypoglycemic |(first |generation |sulfonylurea). |It |lowers |blood |glucose
|levels |by |enhancing |pancreatic |beta-cell |insulin |secretion |(primary |use). |It |also |potentiates |the
|action |(not |suppresses |the |release) |of |small |or |residual |amounts |of |circulating |vasopressin |
(ADH), |making |it |useful |in |treating |diabetes |insipidus |(hyposecretion |of |ADH). |Usual |dosing |in |
diabetes |insipidus |is |125-500 |mg |daily. |
Contraindications |include |liver |disease |(not |heart |disease) |and |renal |insufficiency.
, In |patients |with |diabetes |mellitus |who |have |normal |renal |function, |protein |intake |should |be:
A. |30%-35% |of |daily |caloric |intake
B. |20%-25% |of |daily |caloric |intake
C. |15%-20% |of |daily |caloric |intake
D. |5%-10% |of |daily |caloric |intake |- |CORRECT |ANSWER✔✔-C. |15%-20% |of |daily |caloric |intake
In |patients |with |diabetes |mellitus, |who |have |normal |renal |function, |there |is |little |evidence |to |
suggest |that |usual |protein |intake |(15-20% |of |daily |caloric |intake) |should |be |modified. |With |
evidence |of |neuropathy, |it |may |be |necessary |to |restrict |protein |to |the |adult.
You |are |caring |for |a |patient |with |Type |2 |diabetes |mellitus |who |has |been |prescribed |glipizide |
(Glucotrol), |an |oral |antidiabetic |agent, |for |trouble |controlling |blood |glucose |levels |through |diet
|and |exercise |alone. |Which |medication |instruction |should |you |provide |to |the |patient?
A. |"After |you |start |taking |glipizide, |you |won't |need |to |check |your |blood |glucose |levels |
anymore."
B. |"Take |glipizide |after |meals |to |prevent |heartburn."
C. |"Glipizide |may |cause |a |low |serum |sodium |level, |so |be |sure |to |have |your |sodium |level |
checked |monthly."
D. |"Be |sure |to |take |glipizide |30 |minutes |before |meals." |- |CORRECT |ANSWER✔✔-D. |"Be |sure |to
|take |glipizide |30 |minutes |before |meals."
The |patient |should |be |instructed |to |take |glipizide |twice |a |day, |30 |minutes |before |a |meal |
because |food |decreases |its |absorption.
All |of |the |following |statements |related |to |carbohydrate |intake |in |the |diabetic |patient |are |true |
except:
A. |Low-carbohydrate |diets |which |restrict |total |carbohydrates |to |less |than |130/g |day |are |
recommended |in |the |management |of |diabetes |mellitus
